Invion (AU:IVX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Invion Limited has issued over half a million new shares and is in talks with RMW Cho Group Limited to potentially expand its Photosoft™ technology rights. Known for advancing photodynamic therapy for cancer treatment, Invion is leveraging its ASX listing to drive innovation in the medical field. These developments could impact the company’s market position and attract investor interest.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
